Vimarsana
Biggest News Aggregation in the World

Page 26 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Data Bridge Market Research: Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview - Vimarsana News

Data Bridge Market Research: Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview

MONTREAL, Feb. 7, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published the comprehensive business research on "Exosome Research Products Market " includes historic data, present

Oncodesign Services looks to the future - Vimarsana News

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future.

Lonza Delivers Strong 2022 Performance with 15.1% CER Sales Growth and 32.1% CORE EBITDA Margin - Vimarsana News

Lonza Delivers Strong 2022 Performance with 15.1% CER Sales Growth and 32.1% CORE EBITDA Margin

Lonza Group AG / Key word(s): Annual Results25-Jan-2023 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR In 2022, Lonza delivered CHF 6.2 billion sales and 15.1%1 CER sales growth C...

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2 - Vimarsana News

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

In a recent study posted to bioRxiv* preprint server, researchers in the United States identified several potent pan-coronavirus (CoV) inhibitors.

Alzheimer's Disease Therapeutics Market Report Research 2022: Increasing Gap of Unmet Need of Effective Therapeutics - Vimarsana News

Alzheimer's Disease Therapeutics Market Report Research 2022: Increasing Gap of Unmet Need of Effective Therapeutics

/PRNewswire/ -- The "Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of...